Boston Scientific initiated with an Outperform at Bernstein. Bernstein analyst Lee Hambright started Boston Scientific with an Outperform rating and $38 price target as he expects 390bps of operating margin expansion over the next 3 years, continued execution on growth priorities, and additional bolt-on M&A.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.